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promoting substances acting on hematopoietic progenitors, mainly EPO. 4 Secondary congenital erythrocytosis is characterized by inappropriately normal or high serum EPO levels due to defects in the oxygen sensing pathway (ECYT2-5) or variants effecting hemoglobin oxygen affinity (ECYT6-7) 8 (OMIM). 9 Defects in oxygen sensing pathway can be associated with pathogenic variants in one of the factors regulating EPO production; including von Hippel-Lindau tumor suppressor (VHL) indicative for ECYT2, egl-9 family hypoxiainducible factor 1 (EGLN1, synonym PHD2) indicative for ECYT3, and endothelial PAS domain protein 1 (EPAS1, synonym HIF2A) indicative for ECYT4. Recently, the EPO gene was added to the OMIM database as new cause for FE (indicative for ECYT5). 9, 10 Glycoprotein hormone EPO is the main regulator of red blood cell production. EPOR dimerization and activation by EPO leads to signaling cascade triggering several genes responsible for proliferation, survival, and differentiation of erythroid progenitor cells, leading to a tight control of RBC production in the bone marrow. 11 Hormone EPO and its receptor EPOR can therefore be involved in development of FE. 
| MATERIAL AND ME THODS

| RE SULTS
The review revealed that 25 genetic variants of the exon 8 of (Table 1) . Mutations result in premature termination and, consequently, these mutant receptors lack portions of the C-terminal EPOR cytoplasmic domain responsible for negative regulation.
Out of 11 tested sequence variants of the EPO gene, seven were associated with erythrocytosis or upper-limit hematocrit (Table 2) . 4, 10, 28, 29 Four tested sequence variants were not associated with FE or clinical signs. 19, 28 The first pathogenic variant of the EPO gene is located in the 5′ UTR region and it was reported by the WGS500 project. It was identified in two independent families with erythrocytosis and is sufficiently substantiated by segregation data to assume its disease causing effect, most probably due to increased EPO regulation. 29 Three variants are located within exons 2 and 4 in patients with FE 4 ; however, the causative for FE needs to be 36 Additionally, variant rs539229161 is located within HNF4A binding region (DR-2).
| D ISCUSS I ON
In conclusion, sequence variants of the EPO gene show potential for further functional analyses based on their location within previously reported regulatory regions, which might enable generating more targeted hypotheses for testing in the future and enable more efficient biomarker development.
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